AstraZeneca Scraps Plan To Expand Vaccine Plant In UK

The government may have strong arguments for denying AstraZeneca's demands, but they may be harder to sustain given the sector - high-growth life sciences; the company - Britain's largest by market ...
Telegraph investigation has found ‘critical’ information was missing from early warnings about vaccine’s side effects ...
AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding ...
The move comes as the company faces ‘several challenges’ around the launching of medicines and timed out patents ...